JeanneMarie(Anthon)LomasDO

Allergy & Immunology • Amherst, NY

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions

Director of Allergy & Immunology

Join to view full profile

Dr. Lomas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lomas' full profile

Already have an account?

Office
500 Corporate Pkwy
Ste 100
Amherst, NY 14226
Phone+1 716-631-0380

Fax+1 716-836-0773

Education & Training

University of Rochester Medical CenterFellowship, Allergy and Immunology, 2013 - 2015
University of Rochester Medical CenterChief Residency, Pediatrics, 2012 - 2013
University of Rochester Medical CenterResidency, Pediatrics, 2009 - 2012
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2009
University at BuffaloBS, Biomedical Sciences, Biochemical Pharmacology, UB honors program, magna cum laude, 2001 - 2005

Certifications & Licensure

NY State License 2011 - 2026
IN State License 2022 - 2025
OH State License 2022 - 2024
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Clinical Trials

Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) Start of enrollment: 2017 May 08
Completed
Phase 3
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age Start of enrollment: 2017 Jul 31
COMPLETED
PHASE3
Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) Start of enrollment: 2017 Nov 02
COMPLETED
PHASE3
AR101 Real-World Open-Label Extension Study Start of enrollment: 2017 Oct 18
Completed
Phase 3
Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children Start of enrollment: 2018 Dec 06
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.
Matthew Greenhawt, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D Arkwright
The Journal of Allergy and Clinical Immunology. in Practice. 2025-02-14
33 citations
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
Matthew Greenhawt, Sayantani B Sindher, Julie Wang, Michael O'Sullivan, George du Toit
The New England Journal of Medicine. 2023-05-11
1 citations
Food protein-induced enterocolitis syndrome: Healthcare utilization and referral patterns among a pediatric cohort.
Jennifer Pier, Theresa Bingemann, Jasdeep Badwal, Daniel Rosloff, Muhammad Pasha
Frontiers in Allergy. 2023-01-01

Press Mentions

How Seasonal Allergies Can Impact Mental HealthAugust 25th, 2023

Professional Memberships